Who is at risk? Clinical features and a predictive model for 30-day mortality in hematologic patients with enterococcal bloodstream infection
In hematologic patients, EBSIs commonly arise as breakthrough infections despite broad-spectrum antibiotic coverage, most often associated with mucosal barrier injury. Our parsimonious risk score enables early identification of patients at high risk of 30-day mortality to guide timely interventions.
Authors
- Zhijian Xiao (ORCID: https://orcid.org/0000-0001-8008-7385)
- F. Zhang
- S. feng
- L. Qiu
- Yizhou Zheng (ORCID: https://orcid.org/0000-0002-8246-5009)
- Erlie Jiang (ORCID: https://orcid.org/0000-0003-0237-6063)
- Sisi Zhen
- Nuobing Yang
- Mingzhe Han
- Yuping Fan
- Jianxiang Wang
- Tingting Zhang
- Xin Chen
- Yingchang Mi
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Clinical Research (US)
- Institute of Hematology & Blood Diseases Hospital (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-03-03
- DOI
- https://doi.org/10.3389/fcimb.2026.1762404
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Xisike Clinical Oncology Research Foundation
- Chinese Academy of Medical Sciences
- Peking Union Medical College
- National Science and Technology Major Project
- Fundamental Research Funds for the Central Universities